On Thursday, Shares of Alder BioPharmaceuticals (NASDAQ: ALDR) inclined 1.10% to $13.83. The stock traded total volume of 188,251 shares lower than the average volume of 1.05M shares. Alder BioPharmaceuticals, Inc. (ALDR), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, recently offered a corporate […]